What if product strategy actually shipped enterprise value?
Robert Connely IV
Product and strategy leadership across the Zelis Price portfolio.
12 functional teams, 104 headcount inside a $1.5B revenue, $385M AEBITDA enterprise. Delivered 122% of digital volume budget. $83M annualized COGS avoided. $16M in-year SG&A out. Led synergy realization across three acquisitions and signed Epic's largest clinical-API vendor deal.
Built the "Digital Operations Machine." Drove 53% YoY CAGR in digital transactions while improving labor productivity 33%. First-ever digital labor savings of $2.6M annualized COGS.
GM of a $92M P&L. Reached Rule of 50 in 2023 (24.3% growth + 27% AEBITDA margin). Delivered 26% incremental IRR against $10.36M of invested capital — 98.3% ROIC. Set new Retrieval-as-a-Service strategy. Scaled CommonWell from 2.5B to 5B monthly API transactions.
$74M P&L. 45% IRR — one of the fastest-growing BUs at CHNG by CAGR. Scaled the clinical network by 400,000+ providers through channel partnerships. Retained 100% of key talent through the cyber-attack and Optum integration.
First named inventor on 7 patents. Built a distributed remote-computing platform to fix a broken healthcare supply chain. Transformed the company to SaaS. 50% revenue CAGR, 30% EBITDA improvement, recapitalization.
Post-acute care transitions SaaS. Idea to first productive use in four months as product visionary and UI developer.
Led strategic partnerships in China. Global product lead and architect for three clinical-research products with Quintiles for trials in the US and Scotland. One US patent grant.
PM for INEXX — a clinical-data integration platform. Helped position the company for the $500M Aetna acquisition; presented the product vision and strategy directly to Aetna.
Second employee. Owned executive relationships with 23 core customers representing 700+ hospitals. Where it started.
98.3% ROIC. 26% IRR. Rule of 50. The job is to build products whose unit economics earn the right to scale — and then to actually scale them.
Eight USPTO patents. Multiple products taken from a whiteboard to Fortune-500 deployment. The strategy deck is downstream of someone deciding to actually build the thing.
Capital allocation, DCF, LBO, contribution margin — these aren't separate from product. They're the discipline that lets product decisions hold up in front of a PE sponsor.
Product & strategy leadership
Product and strategy leadership across the Zelis Price portfolio.
Product Strategy · Healthcare Payments
Capital Allocation Manager
A SaaS for product capital-allocation decisions. Brings PE-grade financial discipline — DCF, IRR, contribution margin, build / buy / partner — into the product development lifecycle, so every investment is justified before it ships.
Next.js · TypeScript · DCF · PDLC
iamcam.ai$83M COGS avoided. 122% of plan.
Unified framework spanning solutions consulting, recruitment, implementations, BPO, and analytics. Transformed how clinical data gets exchanged across a 9,000-person enterprise.
Datavant · Epic API · Snowflake · Sigma BI
$92M P&L. 98.3% ROIC.
New RaaS product strategy at Optum Insight. Capital reallocation, vendor renegotiation, and SG&A discipline turned a slow-moving GM into Rule of 50.
Optum · CommonWell · Clinical APIs · P&L
Co-founder. 7 patents.
Distributed remote-computing platform for healthcare. Built the product, transformed the model to SaaS, recapitalized the company, and grew bookings 15x in eleven months post-MVP.
SaaS · Cloud · Distributed Systems · Recap
Inventor on the products that made the P&Ls real
Patent portfolio spanning distributed compute, clinical data exchange, and IP defended through USPTO office actions. The technical foundation behind the business outcomes.
USPTO · Distributed Compute · Clinical Data · IP
If you're building something that matters, let's talk.